SBC

SBC Medical Group Holdings Incorporated · NASDAQ · Industrials · USD · 10-K for 2025, filed 2026-03-27

Figures on this page computed 2026-11-08 12:40 UTC

Last close

5.32USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-27

10.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
30.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
29.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
13.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
0.21Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.93x

1.42x

1.59x

2.38x

0.69x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales0.93x
Its own average over 4 years, 186.7M.
Profit1.42x
Its own average over 4 years, 35.8M.
Free cash flow1.59x
Its own average over 4 years, 14.6M.
Debt2.38x
Its own average over 4 years, 21.8M.
Price0.69x
Its own average over 5 years, 8. Market data, 2026-11-04

Debt is furthest from its own average, at 2.38 times.

Sales is 0.93 times its own 4-year average; Profit is 1.42 times its own 4-year average; Free cash flow is 1.59 times its own 4-year average; Debt is 2.38 times its own 4-year average; Price is 0.69 times its own 5-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales against its own 4-year average0.93
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Profit against its own 4-year average1.42
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Free cash flow against its own 4-year average1.59
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Debt against its own 4-year average2.38
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Price against its own 5-year average0.69Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD